| Year |
Citation |
Score |
| 2024 |
Kotsopoulos J, Gronwald J, Huzarski T, Møller P, Pal T, McCuaig JM, Singer CF, Karlan BY, Aeilts A, Eng C, Eisen A, Bordeleau L, Foulkes WD, Tung N, Couch FJ, ... ... Metcalfe K, et al. Bilateral Oophorectomy and All-Cause Mortality in Women With BRCA1 and BRCA2 Sequence Variations. Jama Oncology. PMID 38421677 DOI: 10.1001/jamaoncol.2023.6937 |
0.566 |
|
| 2024 |
Lubinski J, Kotsopoulos J, Moller P, Pal T, Eisen A, Peck L, Karlan BY, Aeilts A, Eng C, Bordeleau L, Foulkes WD, Tung N, Couch FJ, Fruscio R, Ramon Y Cajal T, ... ... Metcalfe K, et al. MRI Surveillance and Breast Cancer Mortality in Women With BRCA1 and BRCA2 Sequence Variations. Jama Oncology. PMID 38421676 DOI: 10.1001/jamaoncol.2023.6944 |
0.635 |
|
| 2023 |
Metcalfe K, Huzarski T, Gronwald J, Kotsopoulos J, Kim R, Moller P, Pal T, Aeilts A, Eisen A, Karlan B, Bordeleau L, Tung N, Olopade O, Zakalik D, Singer CF, et al. Risk-reducing mastectomy and breast cancer mortality in women with a BRCA1 or BRCA2 pathogenic variant: an international analysis. British Journal of Cancer. PMID 38030749 DOI: 10.1038/s41416-023-02503-8 |
0.675 |
|
| 2023 |
Metcalfe KA, Pal T, Narod SA, Armel S, Shickh S, Buckley K, Walters ST, Brennenstuhl S, Kinney AY. Theory-based behavior change intervention to increase uptake of risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 pathogenic variant: The PREVENT randomized controlled trial. Cancer Medicine. PMID 37602539 DOI: 10.1002/cam4.6417 |
0.483 |
|
| 2023 |
Kotsopoulos J, Gronwald J, Huzarski T, Aeilts A, Randall Armel S, Karlan B, Singer CF, Eisen A, Tung N, Olopade O, Bordeleau L, Eng C, Foulkes WD, Neuhausen SL, Cullinane CA, ... ... Metcalfe K, et al. Tamoxifen and the risk of breast cancer in women with a BRCA1 or BRCA2 mutation. Breast Cancer Research and Treatment. 201: 257-264. PMID 37432545 DOI: 10.1007/s10549-023-06991-3 |
0.714 |
|
| 2023 |
Evans DG, Phillips KA, Milne RL, Fruscio R, Cybulski C, Gronwald J, Lubinski J, Huzarski T, Hyder Z, Forde C, Metcalfe K, Senter L, Weitzel J, Tung N, Zakalik D, et al. Correction to: Survival from breast cancer in women with a BRCA2 mutation by treatment. British Journal of Cancer. PMID 36639528 DOI: 10.1038/s41416-022-02130-9 |
0.688 |
|
| 2022 |
Metcalfe KA, Gronwald J, Tung NM, McCuaig JM, Eisen A, Elser C, Foulkes WD, Neuhausen SL, Senter L, Moller P, Bordeleau L, Fruscio R, Velsher L, Zakalik D, Olopade OI, et al. The risks of cancer in older women with BRCA pathogenic variants: How far have we come? Cancer. PMID 36571512 DOI: 10.1002/cncr.34615 |
0.606 |
|
| 2022 |
Metcalfe KA, Narod SA, Eisen A, Poll A, Zamani N, McCready D, Cil TD, Wright FC, Lerner-Ellis J, McCuaig J, Graham T, Sun P, Akbari MR. Genetic testing women with newly diagnosed breast cancer: What criteria are the most predictive of a positive test? Cancer Medicine. PMID 36544278 DOI: 10.1002/cam4.5515 |
0.605 |
|
| 2022 |
Tindale LC, Zhantuyakova A, Lam S, Woo M, Kwon JS, Hanley GE, Knoppers B, Schrader KA, Peacock SJ, Talhouk A, Dummer T, Metcalfe K, Pashayan N, Foulkes WD, Manchanda R, et al. Gynecologic Cancer Risk and Genetics: Informing an Ideal Model of Gynecologic Cancer Prevention. Current Oncology (Toronto, Ont.). 29: 4632-4646. PMID 35877228 DOI: 10.3390/curroncol29070368 |
0.418 |
|
| 2022 |
Carlsson L, Thain E, Gillies B, Metcalfe K. Psychological and health behaviour outcomes following multi-gene panel testing for hereditary breast and ovarian cancer risk: a mini-review of the literature. Hereditary Cancer in Clinical Practice. 20: 25. PMID 35733200 DOI: 10.1186/s13053-022-00229-x |
0.412 |
|
| 2022 |
Kotsopoulos J, Lubiński J, Gronwald J, Menkiszak J, McCuaig J, Metcalfe K, Foulkes WD, Neuhausen SL, Sun S, Karlan BY, Eisen A, Tung N, Olopade OI, Couch FJ, Huzarski T, et al. Bilateral Oophorectomy and the Risk of Breast Cancer in BRCA1 Mutation Carriers: a Reappraisal. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 35477169 DOI: 10.1158/1055-9965.EPI-21-1196 |
0.681 |
|
| 2022 |
Howell DM, Metcalfe K, Kong S, Stephen J, Olivotto IA, Baxter N, Friedenreich CM, Warner E, Akbari MR, McBain K, Narod S, Quan ML. Risk factors for psychological morbidity and the protective role of coping self-efficacy in young women with breast cancer early in diagnosis: a national multicentre cohort study. Breast Cancer Research and Treatment. PMID 35462611 DOI: 10.1007/s10549-022-06576-6 |
0.587 |
|
| 2022 |
McCuaig JM, Ferguson SE, Vicus D, Ott K, Stockley TL, Kim RH, Metcalfe KA. Reflex BRCA1 and BRCA2 tumour genetic testing for high-grade serous ovarian cancer: streamlined for clinicians but what do patients think? Hereditary Cancer in Clinical Practice. 20: 15. PMID 35418215 DOI: 10.1186/s13053-022-00221-5 |
0.357 |
|
| 2022 |
Carmona CA, Yee S, Seminsky M, Glass K, Foong S, Lipson E, Baxter NN, Friedenreich CM, Metcalfe K, Isherwood S, Akbari MR, Narod S, Quan ML, Warner E. ASO Visual Abstract: Surgeon and Patient Reports of Fertility Preservation Referral and Uptake in a Prospective Pan-Canadian Study of Young Women with Breast Cancer. Annals of Surgical Oncology. PMID 35166950 DOI: 10.1245/s10434-022-11340-7 |
0.619 |
|
| 2022 |
Carmona CA, Yee S, Seminsky M, Glass K, Foong S, Lipson E, Baxter NN, Friedenreich CM, Metcalfe K, Isherwood S, Akbari MR, Narod S, Quan ML, Warner E. Surgeon and Patient Reports of Fertility Preservation Referral and Uptake in a Prospective, Pan-Canadian Study of Young Women with Breast Cancer. Annals of Surgical Oncology. PMID 35001240 DOI: 10.1245/s10434-021-11254-w |
0.665 |
|
| 2021 |
Finch A, Metcalfe K, Akbari M, Friedman E, Tung N, Rosen B, Eisen A, Karlan B, Foulkes W, Neuhausen SL, Senter L, McKinnon W, Elser C, Sun P, Narod SA. The Risks of Breast and Ovarian Cancer Associated with the Ashkenazi Jewish Founder Allele BRCA2 6174delT. Clinical Genetics. PMID 34897671 DOI: 10.1111/cge.14098 |
0.679 |
|
| 2021 |
Dossa F, Metcalfe K, Sutradhar R, Little T, Eisen A, Chun K, Meschino WS, Velsher L, Ellis JL, Baxter NN. Building the What Comes Next Cohort for and testing: a descriptive analysis. Cmaj Open. 9: E874-E885. PMID 34870614 DOI: 10.9778/cmajo.20200228 |
0.386 |
|
| 2021 |
Metcalfe KA, Eisen A, Wright F, Poll A, Candib A, McCready D, Cil T, Armel S, Silberman Y, Brennenstuhl S, Narod SA. Impact of rapid genetic testing for BRCA1 and BRCA2 at time of breast cancer diagnosis on psychosocial functioning. Breast Cancer Research and Treatment. 191: 631-641. PMID 34846626 DOI: 10.1007/s10549-021-06457-4 |
0.682 |
|
| 2021 |
Zhong T, Mahajan A, Cowan K, Temple-Oberle C, Porter G, LeBlanc M, Metcalfe K. Identifying the top research priorities in postmastectomy breast cancer reconstruction: a James Lind Alliance priority setting partnership. Bmj Open. 11: e047589. PMID 34462280 DOI: 10.1136/bmjopen-2020-047589 |
0.418 |
|
| 2021 |
Lim DW, Metcalfe KA. ASO Author Reflections: Psychosocial Outcomes After Breast Cancer Treatment. Annals of Surgical Oncology. PMID 33950312 DOI: 10.1245/s10434-021-10017-x |
0.443 |
|
| 2021 |
Narod SA, Gojska N, Sun P, Tryon A, Kotsopoulos J, Metcalfe K, Akbari MR. The Screen Project: Guided Direct-To-Consumer Genetic Testing for Breast Cancer Susceptibility in Canada. Cancers. 13. PMID 33920818 DOI: 10.3390/cancers13081894 |
0.609 |
|
| 2021 |
Lim DW, Retrouvey H, Kerrebijn I, Butler K, O'Neill AC, Cil TD, Zhong T, Hofer SOP, McCready DR, Metcalfe KA. ASO Visual Abstract: Longitudinal Study of Psychosocial Outcomes Following Surgery in Women with Unilateral Nonhereditary Breast Cancer. Annals of Surgical Oncology. PMID 33876350 DOI: 10.1245/s10434-021-10008-y |
0.466 |
|
| 2021 |
Lim DW, Retrouvey H, Kerrebijn I, Butler K, O'Neill AC, Cil TD, Zhong T, Hofer SOP, McCready DR, Metcalfe KA. Longitudinal Study of Psychosocial Outcomes Following Surgery in Women with Unilateral Nonhereditary Breast Cancer. Annals of Surgical Oncology. PMID 33821345 DOI: 10.1245/s10434-021-09928-6 |
0.548 |
|
| 2021 |
Metcalfe KA, Eisen A, Poll A, Candib A, McCready D, Cil T, Wright F, Demsky R, Mancuso T, Sun P, Narod SA. Frequency of Contralateral Prophylactic Mastectomy in Breast Cancer Patients with a Negative BRCA1 and BRCA2 Rapid Genetic Test Result. Annals of Surgical Oncology. PMID 33761021 DOI: 10.1245/s10434-021-09855-6 |
0.691 |
|
| 2021 |
Evans DG, Phillips KA, Milne RL, Fruscio R, Cybulski C, Gronwald J, Lubinski J, Huzarski T, Hyder Z, Forde C, Metcalfe K, Senter L, Weitzel J, Tung N, Zakalik D, et al. Survival from breast cancer in women with a BRCA2 mutation by treatment. British Journal of Cancer. PMID 33597716 DOI: 10.1038/s41416-020-01164-1 |
0.672 |
|
| 2021 |
Lim DW, Metcalfe KA, Narod SA. Bilateral Mastectomy in Women With Unilateral Breast Cancer: A Review. Jama Surgery. PMID 33566074 DOI: 10.1001/jamasurg.2020.6664 |
0.672 |
|
| 2020 |
Metcalfe KA, Candib A, Giannakeas V, Eisen A, Poll A, McCready D, Cil T, Wright FC, Armel S, Ott K, Sun P, Narod SA. The relationship between the predicted risk of death and psychosocial functioning among women with early-stage breast cancer. Breast Cancer Research and Treatment. PMID 33174180 DOI: 10.1007/s10549-020-05992-w |
0.664 |
|
| 2020 |
Mansfield CA, Metcalfe KA, Snyder C, Lindeman GJ, Posner J, Friedman S, Lynch HT, Narod SA, Evans DG, Liede A. Preferences for breast cancer prevention among women with a or mutation. Hereditary Cancer in Clinical Practice. 18: 20. PMID 33014209 DOI: 10.1186/s13053-020-00152-z |
0.718 |
|
| 2020 |
Metcalfe KA, Eisen A, Poll A, Candib A, McCready D, Cil T, Wright F, Lerner-Ellis J, McCuaig J, Graham T, Sun P, Akbari M, Narod SA. Rapid Genetic Testing for BRCA1 and BRCA2 Mutations at the Time of Breast Cancer Diagnosis: An Observational Study. Annals of Surgical Oncology. PMID 32989658 DOI: 10.1245/s10434-020-09160-8 |
0.715 |
|
| 2020 |
McCuaig JM, Care M, Ferguson SE, Kim RH, Stockley TL, Metcalfe KA. Year 1: Experiences of a tertiary cancer centre following implementation of reflex BRCA1 and BRCA2 tumor testing for all high-grade serous ovarian cancers in a universal healthcare system. Gynecologic Oncology. PMID 32674931 DOI: 10.1016/J.Ygyno.2020.06.507 |
0.456 |
|
| 2020 |
Metcalfe KA, Price MA, Mansfield C, Hallett DC, Lindeman GJ, Fairchild A, Posner J, Friedman S, Snyder C, Lynch HT, Evans DG, Narod SA, Liede A. Predictors of long-term cancer-related distress among female BRCA1 and BRCA2 mutation carriers without a cancer diagnosis: an international analysis. British Journal of Cancer. PMID 32393849 DOI: 10.1038/S41416-020-0861-3 |
0.721 |
|
| 2020 |
Barker LC, Dennis CL, Hussain-Shamsy N, Stewart DE, Grigoriadis S, Metcalfe K, Oberlander TF, Schram C, Taylor VH, Vigod SN. Decision-making about antidepressant medication use in pregnancy: a comparison between women making the decision in the preconception period versus in pregnancy. Bmc Psychiatry. 20: 54. PMID 32033547 DOI: 10.1186/S12888-020-2478-8 |
0.302 |
|
| 2020 |
Lim DW, Retrouvey H, Kerrebijn I, Butler K, O'Neill AC, Cil T, Zhong T, Hofer S, McCready DR, Metcalfe KA. Psychosocial outcomes following surgery in women with unilateral, nonhereditary breast cancer. Journal of Clinical Oncology. 38: 570-570. DOI: 10.1200/Jco.2020.38.15_Suppl.570 |
0.638 |
|
| 2019 |
Galica J, Maheu C, Brennenstuhl S, Townsley C, Metcalfe K. Examining Predictors of Fear of Cancer Recurrence Using Leventhal's Commonsense Model: Distinct Implications for Oncology Nurses. Cancer Nursing. PMID 31868820 DOI: 10.1097/Ncc.0000000000000760 |
0.359 |
|
| 2019 |
Yang X, Leslie G, Doroszuk A, Schneider S, Allen J, Decker B, Dunning AM, Redman J, Scarth J, Plaskocinska I, Luccarini C, Shah M, Pooley K, Dorling L, Lee A, ... ... Metcalfe K, et al. Cancer Risks Associated With Germline Pathogenic Variants: An International Study of 524 Families. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1901907. PMID 31841383 DOI: 10.1200/Jco.19.01907 |
0.544 |
|
| 2019 |
Speller B, Metcalfe K, Kennedy ED, Facey M, Greenblatt E, Scheer AS, Warner E, Joy AA, Wright FC, Baxter NN. The "Begin Exploring Fertility Options, Risks and Expectations" (BEFORE) decision aid: development and alpha testing of a fertility tool for premenopausal breast cancer patients. Bmc Medical Informatics and Decision Making. 19: 203. PMID 31660965 DOI: 10.1186/S12911-019-0912-Y |
0.511 |
|
| 2019 |
Metcalfe KA, Retrouvey H, Kerrebijn I, Butler K, O'Neill AC, Cil T, Zhong T, Hofer SOP, McCready DR. Predictors of uptake of contralateral prophylactic mastectomy in women with nonhereditary breast cancer. Cancer. PMID 31435939 DOI: 10.1002/Cncr.32405 |
0.662 |
|
| 2019 |
Moran O, Eisen A, Demsky R, Blackmore K, Knight JA, Panchal S, Ginsburg O, Zbuk K, Yaffe M, Metcalfe KA, Narod SA, Kotsopoulos J. Predictors of mammographic density among women with a strong family history of breast cancer. Bmc Cancer. 19: 631. PMID 31242899 DOI: 10.1186/S12885-019-5855-2 |
0.704 |
|
| 2019 |
Retrouvey H, Kerrebijn I, Metcalfe KA, O'Neill AC, McCready DR, Hofer SOP, Zhong T. Psychosocial Functioning in Women with Early Breast Cancer Treated with Breast Surgery With or Without Immediate Breast Reconstruction. Annals of Surgical Oncology. PMID 31062209 DOI: 10.1245/S10434-019-07251-9 |
0.577 |
|
| 2019 |
Metcalfe K, Eisen A, Senter L, Armel S, Bordeleau L, Meschino WS, Pal T, Lynch HT, Tung NM, Kwong A, Ainsworth P, Karlan B, Moller P, Eng C, Weitzel JN, et al. International trends in the uptake of cancer risk reduction strategies in women with a BRCA1 or BRCA2 mutation. British Journal of Cancer. PMID 30971774 DOI: 10.1038/S41416-019-0446-1 |
0.718 |
|
| 2019 |
Speller B, Sissons A, Daly C, Facey M, Kennedy E, Metcalfe K, Baxter NN. An evaluation of oncofertility decision support resources among breast cancer patients and health care providers. Bmc Health Services Research. 19: 101. PMID 30728004 DOI: 10.1186/S12913-019-3901-Z |
0.466 |
|
| 2019 |
Metcalfe K, Lynch HT, Foulkes WD, Tung N, Olopade OI, Eisen A, Lerner-Ellis J, Snyder C, Kim SJ, Sun P, Narod SA. Oestrogen receptor status and survival in women with BRCA2-associated breast cancer. British Journal of Cancer. PMID 30723304 DOI: 10.1038/S41416-019-0376-Y |
0.726 |
|
| 2019 |
Metcalfe KA, Poll A, Eisen A, Lerner-Ellis J, Narod S. Outcomes associated with rapid genetic testing for BRCA1 and BRCA2 at time of breast cancer diagnosis. Journal of Clinical Oncology. 37: 1577-1577. DOI: 10.1200/Jco.2019.37.15_Suppl.1577 |
0.7 |
|
| 2019 |
Dossa F, Little T, Metcalfe K, Sutradhar R, Lerner-Ellis J, Meschino W, Eisen A, Baxter NN. What Comes Next? A Cohort Profile of Women Who Have Undergone BRCA1 and BRCA2 Testing in Ontario, Canada Journal of the American College of Surgeons. 229. DOI: 10.1016/J.Jamcollsurg.2019.08.937 |
0.525 |
|
| 2018 |
McCuaig JM, Armel SR, Care M, Volenik A, Kim RH, Metcalfe KA. Next-Generation Service Delivery: A Scoping Review of Patient Outcomes Associated with Alternative Models of Genetic Counseling and Genetic Testing for Hereditary Cancer. Cancers. 10. PMID 30428547 DOI: 10.3390/Cancers10110435 |
0.329 |
|
| 2018 |
Hall E, Finch A, Jacobson M, Rosen B, Metcalfe K, Sun P, Narod SA, Kotsopoulos J. Effects of bilateral salpingo-oophorectomy on menopausal symptoms and sexual functioning among women with a BRCA1 or BRCA2 mutation. Gynecologic Oncology. PMID 30414741 DOI: 10.1016/J.Ygyno.2018.10.040 |
0.587 |
|
| 2018 |
Ahmed H, Lerner-Ellis J, Cybulski C, Metcalfe K, Lubiński J, Narod SA, Akbari MR. Reply to 'Mutations in RECQL are not associated with breast cancer risk in an Australian population'. Nature Genetics. PMID 30224648 DOI: 10.1038/S41588-018-0233-6 |
0.686 |
|
| 2018 |
Dossa F, Cusimano MC, Sutradhar R, Metcalfe K, Little T, Lerner-Ellis J, Eisen A, Meschino WS, Baxter NN. Real-world health services utilisation and outcomes after and testing in Ontario, Canada: the What Comes Next Cohort Study protocol. Bmj Open. 8: e025317. PMID 30181190 DOI: 10.1136/Bmjopen-2018-025317 |
0.588 |
|
| 2018 |
Galica J, Brennenstuhl S, Maheu C, Townsley C, Metcalfe K. Examining the dimensionality of the Fear of Cancer Recurrence Inventory. Psycho-Oncology. PMID 29998546 DOI: 10.1002/Pon.4839 |
0.444 |
|
| 2018 |
Mor P, Brennenstuhl S, Metcalfe KA. Uptake of Preimplantation Genetic Diagnosis in Female BRCA1 and BRCA2 Mutation Carriers. Journal of Genetic Counseling. PMID 29858758 DOI: 10.1007/S10897-018-0264-2 |
0.678 |
|
| 2018 |
Metcalfe K, Akbari MR, Narod SA. Genetic testing for young women with breast cancer. The Lancet. Oncology. 19: e182. PMID 29611519 DOI: 10.1016/S1470-2045(18)30162-1 |
0.715 |
|
| 2017 |
Metcalfe KA, Lubinski J, Gronwald J, Huzarski T, McCuaig J, Lynch HT, Karlan B, Foulkes WD, Singer CF, Neuhausen SL, Senter L, Eisen A, Sun P, Narod SA. The Risk of Breast Cancer in BRCA1 and BRCA2 Mutation Carriers without a First-Degree Relative with Breast Cancer. Clinical Genetics. PMID 29206279 DOI: 10.1111/Cge.13191 |
0.739 |
|
| 2017 |
Metcalfe K, Zhong T, O'Neill AC, McCready D, Chan L, Butler K, Brennenstuhl S, Hofer SOP. Development and testing of a decision aid for women considering delayed breast reconstruction. Journal of Plastic, Reconstructive & Aesthetic Surgery : Jpras. PMID 28958567 DOI: 10.1016/J.Bjps.2017.08.027 |
0.498 |
|
| 2017 |
McInerney NM, Narod S, Metcalfe K, Semple J, Brown MH. Breast Cancer Genetics for Plastic Surgeons. Plastic and Reconstructive Surgery. 140: 455-460. PMID 28841602 DOI: 10.1097/Prs.0000000000003577 |
0.624 |
|
| 2017 |
Liede A, Mansfield CA, Metcalfe KA, Price MA, Snyder C, Lynch HT, Friedman S, Amelio J, Posner J, Narod SA, Lindeman GJ, Evans DG. Preferences for breast cancer risk reduction among BRCA1/BRCA2 mutation carriers: a discrete-choice experiment. Breast Cancer Research and Treatment. PMID 28624978 DOI: 10.1007/S10549-017-4332-3 |
0.712 |
|
| 2017 |
L Semple J, Metcalfe K, Shoukat F, Sun P, Narod S. Survival Differences in Women with and without Autologous Breast Reconstruction after Mastectomy for Breast Cancer. Plastic and Reconstructive Surgery. Global Open. 5: e1281. PMID 28507852 DOI: 10.1097/Gox.0000000000001281 |
0.668 |
|
| 2017 |
Metcalfe KA, Semple J, Quan ML, Holloway C, Wright F, Narod S, Hofer S, Bagher S, Zhong T. Why Some Mastectomy Patients Opt to Undergo Delayed Breast Reconstruction: Results of a Long-Term Prospective Study. Plastic and Reconstructive Surgery. 139: 267-275. PMID 28121851 DOI: 10.1097/Prs.0000000000002943 |
0.603 |
|
| 2017 |
Kotsopoulos J, Huzarski T, Gronwald J, Singer CF, Moller P, Lynch HT, Armel S, Karlan B, Foulkes WD, Neuhausen SL, Senter L, Tung N, Weitzel JN, Eisen A, Metcalfe K, et al. Bilateral Oophorectomy and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers. Journal of the National Cancer Institute. 109. PMID 27601060 DOI: 10.1093/Jnci/Djw177 |
0.714 |
|
| 2017 |
Speller B, Facey M, Sissons A, Daly C, Kennedy ED, Metcalfe KA, Baxter NN. Development of a decision aid for young canadians diagnosed with breast cancer who are at risk of infertility following cancer treatment. Journal of Clinical Oncology. 35: 108-108. DOI: 10.1200/Jco.2017.35.5_Suppl.108 |
0.563 |
|
| 2017 |
Metcalfe KA, Akbari MR, Narod S, Lerner-Ellis J. PALB2 mutations in high-risk women with breast or ovarian cancer. Journal of Clinical Oncology. 35: 1527-1527. DOI: 10.1200/Jco.2017.35.15_Suppl.1527 |
0.763 |
|
| 2017 |
Moran OM, Nikitina D, Gunasekara A, Yaffe MJ, Metcalfe KA, Narod SA, Kotsopoulos J. Abstract B12: The effect of physical activity and body size on mammographic density in high-risk, BRCA mutation-negative women Cancer Epidemiology and Prevention Biomarkers. 26. DOI: 10.1158/1538-7755.Carisk16-B12 |
0.673 |
|
| 2017 |
Liede A, Evans G, Metcalfe K, Price M, Snyder C, Lynch H, Friedman S, Amelio J, Posner J, Lindeman G, Mansfield C. Abstract P3-08-08: Preferences for breast cancer risk reduction amongBRCA1andBRCA2mutation carriers: A discrete choice experiment Cancer Research. 77. DOI: 10.1158/1538-7445.Sabcs16-P3-08-08 |
0.566 |
|
| 2016 |
Moran O, Nikitina D, Royer R, Poll A, Metcalfe K, Narod SA, Akbari MR, Kotsopoulos J. Revisiting breast cancer patients who previously tested negative for BRCA mutations using a 12-gene panel. Breast Cancer Research and Treatment. PMID 27798748 DOI: 10.1007/S10549-016-4038-Y |
0.725 |
|
| 2016 |
Zhong T, Hu J, Bagher S, Vo A, OʼNeill AC, Butler K, Novak CB, Hofer SO, Metcalfe KA. A Comparison of Psychological Response, Body Image, Sexuality, and Quality of Life between Immediate and Delayed Autologous Tissue Breast Reconstruction: A Prospective Long-Term Outcome Study. Plastic and Reconstructive Surgery. 138: 772-780. PMID 27673514 DOI: 10.1097/Prs.0000000000002536 |
0.403 |
|
| 2016 |
Metcalfe KA, Dennis CL, Poll A, Armel S, Demsky R, Carlsson L, Nanda S, Kiss A, Narod SA. Effect of decision aid for breast cancer prevention on decisional conflict in women with a BRCA1 or BRCA2 mutation: a multisite, randomized, controlled trial. Genetics in Medicine : Official Journal of the American College of Medical Genetics. PMID 27584910 DOI: 10.1038/Gim.2016.108 |
0.743 |
|
| 2016 |
Vigod S, Hussain-Shamsy N, Grigoriadis S, Howard LM, Metcalfe K, Oberlander TF, Schram C, Stewart DE, Taylor VH, Dennis CL. A patient decision aid for antidepressant use in pregnancy: study protocol for a randomized controlled trial. Trials. 17: 110. PMID 26923796 DOI: 10.1186/S13063-016-1233-4 |
0.303 |
|
| 2016 |
Metcalfe KA, Narod S, Eisen A, Lerner-Ellis J. Treatment decision making and psychosocial outcomes associated with rapid genetic testing for BRCA1 and BRCA2 in women newly diagnosed with breast cancer. Journal of Clinical Oncology. 34: 1586-1586. DOI: 10.1200/Jco.2016.34.15_Suppl.1586 |
0.673 |
|
| 2016 |
Liede A, Fairchild A, Friedman S, Amelio J, Hallett D, Mansfield C, Metcalfe K. Abstract P2-09-09: Risk-reducing surgery and cancer-related distress among femaleBRCA1andBRCA2mutation carriers: Cancer Research. 76. DOI: 10.1158/1538-7445.Sabcs15-P2-09-09 |
0.673 |
|
| 2015 |
Semple J, Metcalfe KA, Lubinski J, Huzarski T, Gronwald J, Armel S, Lynch HT, Karlan B, Foulkes W, Singer CF, Neuhausen SL, Eng C, Iqbal J, Narod SA. Does the age of breast cancer diagnosis in first-degree relatives impact on the risk of breast cancer in BRCA1 and BRCA2 mutation carriers? Breast Cancer Research and Treatment. 154: 163-9. PMID 26467043 DOI: 10.1007/S10549-015-3596-8 |
0.751 |
|
| 2015 |
Metcalfe KA, Eisen A, Lerner-Ellis J, Narod SA. Is it time to offer BRCA1 and BRCA2 testing to all Jewish women? Current Oncology (Toronto, Ont.). 22: e233-6. PMID 26300672 DOI: 10.3747/Co.22.2527 |
0.52 |
|
| 2015 |
Finch A, Wang M, Fine A, Atri L, Khalouei S, Pupavac M, Rosen B, Eisen A, Elser C, Charames G, Metcalfe K, Chang MC, Narod SA, Lerner-Ellis J. Genetic testing for BRCA1 and BRCA2 in the Province of Ontario. Clinical Genetics. PMID 26219728 DOI: 10.1111/Cge.12647 |
0.662 |
|
| 2015 |
Metcalfe KA, Cil TD, Semple JL, Li LD, Bagher S, Zhong T, Virani S, Narod S, Pal T. Long-Term Psychosocial Functioning in Women with Bilateral Prophylactic Mastectomy: Does Preservation of the Nipple-Areolar Complex Make a Difference? Annals of Surgical Oncology. PMID 26208581 DOI: 10.1245/S10434-015-4761-3 |
0.678 |
|
| 2015 |
Metcalfe K, Lynch HT, Foulkes WD, Tung N, Kim-Sing C, Olopade OI, Eisen A, Rosen B, Snyder C, Gershman S, Sun P, Narod SA. Effect of Oophorectomy on Survival After Breast Cancer in BRCA1 and BRCA2 Mutation Carriers. Jama Oncology. 1: 306-13. PMID 26181175 DOI: 10.1001/Jamaoncol.2015.0658 |
0.756 |
|
| 2015 |
Snyder C, Metcalfe K, Sopik V, Royer R, Zhang S, Narod SA, Akbari MR, Lynch HT. Prevalence of PALB2 mutations in the Creighton University Breast Cancer Family Registry. Breast Cancer Research and Treatment. 150: 637-41. PMID 25794774 DOI: 10.1007/S10549-015-3347-X |
0.707 |
|
| 2015 |
Metcalfe KA, Zhong T, Narod SA, Quan ML, Holloway C, Hofer S, Bagher S, Semple J. A prospective study of mastectomy patients with and without delayed breast reconstruction: long-term psychosocial functioning in the breast cancer survivorship period. Journal of Surgical Oncology. 111: 258-64. PMID 25557452 DOI: 10.1002/Jso.23829 |
0.64 |
|
| 2015 |
Causarano N, Platt J, Baxter NN, Bagher S, Jones JM, Metcalfe KA, Hofer SO, O'Neill AC, Cheng T, Starenkyj E, Zhong T. Pre-consultation educational group intervention to improve shared decision-making for postmastectomy breast reconstruction: a pilot randomized controlled trial. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. 23: 1365-75. PMID 25351455 DOI: 10.1007/S00520-014-2479-6 |
0.49 |
|
| 2015 |
Metcalfe KA, Poll A, Llacuachaqui M, Virani S, Nanda S, Sun P, Narod S. Patient-reported outcomes associated with population-based Jewish genetic testing for BRCA1 and BRCA2. Journal of Clinical Oncology. 33: 1531-1531. DOI: 10.1200/Jco.2015.33.15_Suppl.1531 |
0.704 |
|
| 2015 |
Visscher K, Metcalfe KA, Semple JL. Breast deformity and reconstruction in Turner syndrome: A collection of case studies Jpras Open. 4: 16-21. DOI: 10.1016/J.Jpra.2015.03.002 |
0.506 |
|
| 2014 |
Zhong T, Novak CB, Bagher S, Maass SW, Zhang J, Arad U, O'Neill AC, Metcalfe KA, Hofer SO. Using propensity score analysis to compare major complications between DIEP and free muscle-sparing TRAM flap breast reconstructions. Plastic and Reconstructive Surgery. 133: 774-82. PMID 24675183 DOI: 10.1097/Prs.0000000000000024 |
0.395 |
|
| 2014 |
Kotsopoulos J, Metcalfe K, Alston J, Nikitina D, Ginsburg O, Eisen A, Demsky R, Akbari M, Zbuk K, Narod SA. Prospective study of high-risk, BRCA1/2-mutation negative women: the 'negative study'. Bmc Cancer. 14: 221. PMID 24667084 DOI: 10.1186/1471-2407-14-221 |
0.702 |
|
| 2014 |
Finch AP, Lubinski J, Møller P, Singer CF, Karlan B, Senter L, Rosen B, Maehle L, Ghadirian P, Cybulski C, Huzarski T, Eisen A, Foulkes WD, Kim-Sing C, Ainsworth P, ... ... Metcalfe KA, et al. Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 1547-53. PMID 24567435 DOI: 10.1200/Jco.2013.53.2820 |
0.642 |
|
| 2014 |
Baltzer HL, Alonzo-Proulx O, Mainprize JG, Yaffe MJ, Metcalfe KA, Narod SA, Warner E, Semple JL. MRI volumetric analysis of breast fibroglandular tissue to assess risk of the spared nipple in BRCA1 and BRCA2 mutation carriers. Annals of Surgical Oncology. 21: 1583-8. PMID 24526546 DOI: 10.1245/S10434-014-3532-X |
0.594 |
|
| 2014 |
Metcalfe K, Gershman S, Ghadirian P, Lynch HT, Snyder C, Tung N, Kim-Sing C, Eisen A, Foulkes WD, Rosen B, Sun P, Narod SA. Contralateral mastectomy and survival after breast cancer in carriers of BRCA1 and BRCA2 mutations: retrospective analysis. Bmj (Clinical Research Ed.). 348: g226. PMID 24519767 DOI: 10.1136/Bmj.G226 |
0.717 |
|
| 2014 |
Metcalfe KA, Kim-Sing C, Ghadirian P, Sun P, Narod SA. Health care provider recommendations for reducing cancer risks among women with a BRCA1 or BRCA2 mutation. Clinical Genetics. 85: 21-30. PMID 23859469 DOI: 10.1111/Cge.12233 |
0.68 |
|
| 2014 |
Pal T, Lee JH, Besharat A, Thompson Z, Monteiro AN, Phelan C, Lancaster JM, Metcalfe K, Sellers TA, Vadaparampil S, Narod SA. Modes of delivery of genetic testing services and the uptake of cancer risk management strategies in BRCA1 and BRCA2 carriers. Clinical Genetics. 85: 49-53. PMID 23438721 DOI: 10.1111/Cge.12130 |
0.381 |
|
| 2014 |
Metcalfe KA, Lynch HT, Snyder CL, Foulkes W, Tung NM, Kim-Sing C, Olopade OI, Eisen A, Rosen B, Sun P, Narod S. The impact of oophorectomy on survival after breast cancer in BRCA1 and BRCA2 mutation carriers. Journal of Clinical Oncology. 32: 1507-1507. DOI: 10.1200/Jco.2014.32.15_Suppl.1507 |
0.735 |
|
| 2013 |
Zhong T, Hu J, Bagher S, O'Neill AC, Beber B, Hofer SO, Metcalfe KA. Decision regret following breast reconstruction: the role of self-efficacy and satisfaction with information in the preoperative period. Plastic and Reconstructive Surgery. 132: 724e-734e. PMID 24165624 DOI: 10.1097/Prs.0B013E3182A3Bf5D |
0.4 |
|
| 2013 |
Zhong T, Bagher S, Jindal K, Zeng D, O'Neill AC, MacAdam S, Butler K, Hofer SO, Pusic A, Metcalfe KA. The influence of dispositional optimism on decision regret to undergo major breast reconstructive surgery. Journal of Surgical Oncology. 108: 526-30. PMID 24105811 DOI: 10.1002/jso.23437 |
0.448 |
|
| 2013 |
Platt J, Baxter N, Jones J, Metcalfe K, Causarano N, Hofer SO, O'Neill A, Cheng T, Starenkyj E, Zhong T. Pre-consultation educational group intervention to improve shared decision-making in postmastectomy breast reconstruction: study protocol for a pilot randomized controlled trial. Trials. 14: 199. PMID 23829442 DOI: 10.1186/1745-6215-14-199 |
0.383 |
|
| 2013 |
Metcalfe KA, Poll A, Royer R, Nanda S, Llacuachaqui M, Sun P, Narod SA. A comparison of the detection of BRCA mutation carriers through the provision of Jewish population-based genetic testing compared with clinic-based genetic testing. British Journal of Cancer. 109: 777-9. PMID 23778531 DOI: 10.1038/Bjc.2013.309 |
0.561 |
|
| 2013 |
Semple J, Metcalfe KA, Lynch HT, Kim-Sing C, Senter L, Pal T, Ainsworth P, Lubinski J, Tung N, Eng C, Gilchrist D, Blum J, Neuhausen SL, Singer CF, Ghadirian P, et al. International rates of breast reconstruction after prophylactic mastectomy in BRCA1 and BRCA2 mutation carriers. Annals of Surgical Oncology. 20: 3817-22. PMID 23740344 DOI: 10.1245/S10434-013-3040-4 |
0.713 |
|
| 2013 |
Pal T, Vadaparampil S, Kim J, Xu Y, Friedman S, Narod SA, Metcalfe K. Interest of individuals from BRCA families to participate in research studies focused on male BRCA carriers. Familial Cancer. 12: 615-9. PMID 23504063 DOI: 10.1007/S10689-013-9624-0 |
0.543 |
|
| 2013 |
Metcalfe KA, Quan ML, Eisen A, Cil T, Sun P, Narod SA. The impact of having a sister diagnosed with breast cancer on cancer-related distress and breast cancer risk perception. Cancer. 119: 1722-8. PMID 23400407 DOI: 10.1002/Cncr.27924 |
0.686 |
|
| 2013 |
Narod SA, Metcalfe K, Lynch HT, Ghadirian P, Robidoux A, Tung N, Gaughan E, Kim-Sing C, Olopade OI, Foulkes WD, Robson M, Offit K, Jakubowska A, Byrski T, Huzarski T, et al. Should all BRCA1 mutation carriers with stage i breast cancer receive chemotherapy? Breast Cancer Research and Treatment. 138: 273-279. PMID 23381743 DOI: 10.1007/S10549-013-2429-X |
0.711 |
|
| 2013 |
Finch A, Metcalfe KA, Chiang J, Elit L, McLaughlin J, Springate C, Esplen MJ, Demsky R, Murphy J, Rosen B, Narod SA. The impact of prophylactic salpingo-oophorectomy on quality of life and psychological distress in women with a BRCA mutation. Psycho-Oncology. 22: 212-9. PMID 21913283 DOI: 10.1002/Pon.2041 |
0.51 |
|
| 2013 |
Baltzer H, Alonzo O, Yaffe M, Narod S, Metcalfe KA, Warner E, Semple J. MRI volumetric analysis of fibroglandular tissue to assess risk of the spared nipple in BRCA 1/2 patients who are considering prophylactic nipple-sparing mastectomy. Journal of Clinical Oncology. 31: 1507-1507. DOI: 10.1200/Jco.2013.31.15_Suppl.1507 |
0.596 |
|
| 2012 |
Lam A, Secord S, Butler K, Hofer SO, Liu E, Metcalfe KA, Zhong T. A breast reconstruction needs assessment: How does self-efficacy affect information access and preferences? The Canadian Journal of Plastic Surgery = Journal Canadien De Chirurgie Plastique. 20: 37-42. PMID 23598765 DOI: 10.1177/229255031202000101 |
0.481 |
|
| 2012 |
Wong J, D'Alimonte L, Angus J, Paszat L, Metcalfe K, Whelan T, Llewellyn-Thomas H, Warner E, Franssen E, Szumacher E. Development of patients' decision aid for older women with stage I breast cancer considering radiotherapy after lumpectomy. International Journal of Radiation Oncology, Biology, Physics. 84: 30-8. PMID 22331002 DOI: 10.1016/J.Ijrobp.2011.11.028 |
0.528 |
|
| 2012 |
Metcalfe KA, Mian N, Enmore M, Poll A, Llacuachaqui M, Nanda S, Sun P, Hughes KS, Narod SA. Long-term follow-up of Jewish women with a BRCA1 and BRCA2 mutation who underwent population genetic screening. Breast Cancer Research and Treatment. 133: 735-40. PMID 22240989 DOI: 10.1007/S10549-011-1941-0 |
0.726 |
|
| 2012 |
Metcalfe KA, Semple J, Quan ML, Vadaparampil ST, Holloway C, Brown M, Bower B, Sun P, Narod SA. Changes in psychosocial functioning 1 year after mastectomy alone, delayed breast reconstruction, or immediate breast reconstruction. Annals of Surgical Oncology. 19: 233-41. PMID 21674270 DOI: 10.1245/S10434-011-1828-7 |
0.625 |
|
| 2012 |
Ertmański S, Metcalfe K, Trempała J, Głowacka M, Lubiński J, Narod S, Gronwald J. Identification of patients at high risk of negative psychological consequences associated with BRCA1 mutation Hereditary Cancer in Clinical Practice. 10: A14. DOI: 10.1186/1897-4287-10-S1-A14 |
0.545 |
|
| 2012 |
Culver JO, MacDonald DJ, Thornton AA, Sand SR, Grant M, Bowen DJ, Burke H, Garcia N, Metcalfe KA, Weitzel JN. Erratum to: Development and Evaluation of a Decision Aid for BRCA Carriers with Breast Cancer Journal of Genetic Counseling. 22: 406-406. DOI: 10.1007/S10897-012-9513-Y |
0.42 |
|
| 2011 |
Metcalfe K, Gershman S, Lynch HT, Ghadirian P, Tung N, Kim-Sing C, Olopade OI, Domchek S, McLennan J, Eisen A, Foulkes WD, Rosen B, Sun P, Narod SA. Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. British Journal of Cancer. 104: 1384-92. PMID 21487411 DOI: 10.1038/Bjc.2011.120 |
0.705 |
|
| 2011 |
Culver JO, MacDonald DJ, Thornton AA, Sand SR, Grant M, Bowen DJ, Burke H, Garcia N, Metcalfe KA, Weitzel JN. Development and evaluation of a decision aid for BRCA carriers with breast cancer. Journal of Genetic Counseling. 20: 294-307. PMID 21369831 DOI: 10.1007/S10897-011-9350-4 |
0.568 |
|
| 2011 |
Metcalfe K, Lynch HT, Ghadirian P, Tung N, Kim-Sing C, Olopade OI, Domchek S, Eisen A, Foulkes WD, Rosen B, Vesprini D, Sun P, Narod SA. Risk of ipsilateral breast cancer in BRCA1 and BRCA2 mutation carriers. Breast Cancer Research and Treatment. 127: 287-96. PMID 21221768 DOI: 10.1007/S10549-010-1336-7 |
0.73 |
|
| 2011 |
Finch A, Metcalfe KA, Chiang JK, Elit L, McLaughlin J, Springate C, Demsky R, Murphy J, Rosen B, Narod SA. The impact of prophylactic salpingo-oophorectomy on menopausal symptoms and sexual function in women who carry a BRCA mutation. Gynecologic Oncology. 121: 163-8. PMID 21216453 DOI: 10.1016/J.Ygyno.2010.12.326 |
0.663 |
|
| 2011 |
Brown SM, Culver JO, Osann KE, MacDonald DJ, Sand S, Thornton AA, Grant M, Bowen DJ, Metcalfe KA, Burke HB, Robson ME, Friedman S, Weitzel JN. Health literacy, numeracy, and interpretation of graphical breast cancer risk estimates. Patient Education and Counseling. 83: 92-8. PMID 20554149 DOI: 10.1016/J.Pec.2010.04.027 |
0.472 |
|
| 2011 |
Szumacher E, Wong J, D'Alimonte L, Angus J, Paszat L, Metcalfe K, Whelan T, Llewellyn-Thomas H. P5-15-03: Development of a Patient Decision Aid for Women 70 Years and Older with Stage I, Hormonally Sensitive, Breast Cancer Considering Adjuvant Treatment Post-Lumpectomy. Cancer Research. 71. DOI: 10.1158/0008-5472.Sabcs11-P5-15-03 |
0.527 |
|
| 2010 |
Metcalfe K, Lubinski J, Lynch HT, Ghadirian P, Foulkes WD, Kim-Sing C, Neuhausen S, Tung N, Rosen B, Gronwald J, Ainsworth P, Sweet K, Eisen A, Sun P, Narod SA, et al. Family history of cancer and cancer risks in women with BRCA1 or BRCA2 mutations. Journal of the National Cancer Institute. 102: 1874-8. PMID 21098759 DOI: 10.1093/Jnci/Djq443 |
0.745 |
|
| 2010 |
Metcalfe KA, Poll A, Llacuachaqui M, Nanda S, Tulman A, Mian N, Sun P, Narod SA. Patient satisfaction and cancer-related distress among unselected Jewish women undergoing genetic testing for BRCA1 and BRCA2. Clinical Genetics. 78: 411-7. PMID 20653694 DOI: 10.1111/J.1399-0004.2010.01499.X |
0.726 |
|
| 2010 |
Metcalfe KA, Poll A, Royer R, Llacuachaqui M, Tulman A, Sun P, Narod SA. Screening for founder mutations in BRCA1 and BRCA2 in unselected Jewish women. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 28: 387-91. PMID 20008623 DOI: 10.1200/Jco.2009.25.0712 |
0.607 |
|
| 2010 |
Narod SA, Metcalfe KA. Reply to D. Rayson et al Journal of Clinical Oncology. 28: e309-e309. DOI: 10.1200/Jco.2010.29.1146 |
0.578 |
|
| 2009 |
Ertmański S, Metcalfe K, Trempała J, Głowacka MD, Lubiński J, Narod SA, Gronwald J. Identification of patients at high risk of psychological distress after BRCA1 genetic testing. Genetic Testing and Molecular Biomarkers. 13: 325-30. PMID 19405874 DOI: 10.1089/Gtmb.2008.0126 |
0.628 |
|
| 2009 |
Finch A, Metcalfe K, Lui J, Springate C, Demsky R, Armel S, Rosen B, Murphy J, Elit L, Sun P, Narod S. Breast and ovarian cancer risk perception after prophylactic salpingo-oophorectomy due to an inherited mutation in the BRCA1 or BRCA2 gene. Clinical Genetics. 75: 220-4. PMID 19263514 DOI: 10.1111/J.1399-0004.2008.01117.X |
0.705 |
|
| 2009 |
Esplen MJ, Stuckless N, Hunter J, Liede A, Metcalfe K, Glendon G, Narod S, Butler K, Scott J, Irwin E. The BRCA Self-Concept Scale: a new instrument to measure self-concept in BRCA1/2 mutation carriers. Psycho-Oncology. 18: 1216-29. PMID 19180529 DOI: 10.1002/Pon.1498 |
0.493 |
|
| 2009 |
Metcalfe KA. Oophorectomy for breast cancer prevention in women with BRCA1 or BRCA2 mutations. Women's Health (London, England). 5: 63-8. PMID 19102642 DOI: 10.2217/17455057.5.1.63 |
0.684 |
|
| 2009 |
Metcalfe KA, Finch A, Poll A, Horsman D, Kim-Sing C, Scott J, Royer R, Sun P, Narod SA. Breast cancer risks in women with a family history of breast or ovarian cancer who have tested negative for a BRCA1 or BRCA2 mutation. British Journal of Cancer. 100: 421-5. PMID 19088722 DOI: 10.1038/Sj.Bjc.6604830 |
0.755 |
|
| 2009 |
Metcalfe KA, Fan I, McLaughlin J, Risch HA, Rosen B, Murphy J, Bradley L, Armel S, Sun P, Narod SA. Uptake of clinical genetic testing for ovarian cancer in Ontario: a population-based study. Gynecologic Oncology. 112: 68-72. PMID 19019415 DOI: 10.1016/J.Ygyno.2008.10.007 |
0.661 |
|
| 2008 |
Metcalfe KA, Foulkes WD, Kim-Sing C, Ainsworth P, Rosen B, Armel S, Poll A, Eisen A, Gilchrist D, Chudley A, Ghadirian P, Maugard C, Lemire EG, Sun P, Narod SA. Family history as a predictor of uptake of cancer preventive procedures by women with a BRCA1 or BRCA2 mutation. Clinical Genetics. 73: 474-9. PMID 18341607 DOI: 10.1111/J.1399-0004.2008.00988.X |
0.734 |
|
| 2008 |
Metcalfe KA, Birenbaum-Carmeli D, Lubinski J, Gronwald J, Lynch H, Moller P, Ghadirian P, Foulkes WD, Klijn J, Friedman E, Kim-Sing C, Ainsworth P, Rosen B, Domchek S, Wagner T, et al. International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers. International Journal of Cancer. 122: 2017-22. PMID 18196574 DOI: 10.1002/Ijc.23340 |
0.742 |
|
| 2008 |
Metcalfe KA, Lubinski J, Ghadirian P, Lynch H, Kim-Sing C, Friedman E, Foulkes WD, Domchek S, Ainsworth P, Isaacs C, Tung N, Gronwald J, Cummings S, Wagner T, Manoukian S, et al. Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 1093-7. PMID 18195327 DOI: 10.1200/Jco.2007.12.6078 |
0.734 |
|
| 2008 |
Liede A, Metcalfe K, Offit K, Brown K, Miller S, Narod SA, Moslehi R. A family with three germline mutations in BRCA1 and BRCA2. Clinical Genetics. 54: 215-218. PMID 9788724 DOI: 10.1111/J.1399-0004.1998.Tb04287.X |
0.65 |
|
| 2008 |
Metcalfe K, Finch A, Poll A, Horsman D, Kim-Sing C, Scott J, Royer R, Sun P, Narod S. Abstract B7: Breast cancer risks in women with a family history of breast or ovarian cancer who have tested negative for a BRCA1 or BRCA2 mutation Cancer Prevention Research. 1. DOI: 10.1158/1940-6207.Prev-08-B7 |
0.755 |
|
| 2007 |
Metcalfe KA, Narod SA. Breast cancer prevention in women with a BRCA1 or BRCA2 mutation. Open Medicine : a Peer-Reviewed, Independent, Open-Access Journal. 1: e184-90. PMID 21673951 |
0.718 |
|
| 2007 |
Metcalfe KA, Ghadirian P, Rosen B, Foulkes W, Kim-Sing C, Eisen A, Ainsworth P, Horsman D, Maugard C, Provencher D, Robideaux A, Gilchrist D, Chudley A, Lemire EG, Armel S, et al. Variation in rates of uptake of preventive options by Canadian women carrying the BRCA1 or BRCA2 genetic mutation. Open Medicine : a Peer-Reviewed, Independent, Open-Access Journal. 1: e92-8. PMID 20101300 |
0.667 |
|
| 2007 |
Metcalfe KA, Poll A, O'Connor A, Gershman S, Armel S, Finch A, Demsky R, Rosen B, Narod SA. Development and testing of a decision aid for breast cancer prevention for women with a BRCA1 or BRCA2 mutation. Clinical Genetics. 72: 208-17. PMID 17718858 DOI: 10.1111/J.1399-0004.2007.00859.X |
0.712 |
|
| 2006 |
Gronwald J, Huzarski T, Byrski T, Debniak T, Metcalfe K, Narod SA, Lubiński J. Direct-to-patient BRCA1 testing: the Twoj Styl experience. Breast Cancer Research and Treatment. 100: 239-45. PMID 16807675 DOI: 10.1007/S10549-006-9261-5 |
0.698 |
|
| 2006 |
Lynch HT, Snyder C, Lynch JF, Karatoprakli P, Trowonou A, Metcalfe K, Narod SA, Gong G. Patient responses to the disclosure of BRCA mutation tests in hereditary breast-ovarian cancer families. Cancer Genetics and Cytogenetics. 165: 91-7. PMID 16527602 DOI: 10.1016/J.Cancergencyto.2005.07.011 |
0.678 |
|
| 2005 |
Snyder C, Lynch JA, Karatoprakli P, Coronel S, Trowonou A, Metcalfe K, Narod SA, Gong G, Lynch HT. Impact of BRCA mutation test results in members of hereditary breast ovarian cancer (HBOC) families. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 1014. PMID 27944917 DOI: 10.1200/Jco.2005.23.16_Suppl.1014 |
0.664 |
|
| 2005 |
Metcalfe KA, Foulkes WD, Lynch HT, Ghadirian P, Tung N, Olivotto IA, Warner E, Olopade O, Eisen A, Weber B, McLennan J, Sun P, Narod SA. Effect of Prior Bilateral Oophorectomy on the Presentation of Breast Cancer in BRCA1 and BRCA2 Mutation Carriers. Hereditary Cancer in Clinical Practice. 3: 53-7. PMID 20223030 DOI: 10.1186/1897-4287-3-2-53 |
0.706 |
|
| 2005 |
Metcalfe KA, Snyder C, Seidel J, Hanna D, Lynch HT, Narod S. The use of preventive measures among healthy women who carry a BRCA1 or BRCA2 mutation. Familial Cancer. 4: 97-103. PMID 15951959 DOI: 10.1007/S10689-005-4215-3 |
0.612 |
|
| 2005 |
Weitzel JN, Robson M, Pasini B, Manoukian S, Stoppa-Lyonnet D, Lynch HT, McLennan J, Foulkes WD, Wagner T, Tung N, Ghadirian P, Olopade O, Isaacs C, Kim-Sing C, Møller P, ... ... Metcalfe K, et al. A comparison of bilateral breast cancers in BRCA carriers Cancer Epidemiology Biomarkers and Prevention. 14: 1534-1538. PMID 15941968 DOI: 10.1158/1055-9965.Epi-05-0070 |
0.69 |
|
| 2005 |
Metcalfe KA, Semple JL, Narod SA. Time to reconsider subcutaneous mastectomy for breast-cancer prevention? The Lancet. Oncology. 6: 431-4. PMID 15925821 DOI: 10.1016/S1470-2045(05)70210-2 |
0.761 |
|
| 2005 |
Metcalfe KA, Esplen MJ, Goel V, Narod SA. Predictors of quality of life in women with a bilateral prophylactic mastectomy. The Breast Journal. 11: 65-9. PMID 15647082 DOI: 10.1111/J.1075-122X.2005.21546.X |
0.473 |
|
| 2005 |
Metcalfe KA, Lynch HT, Ghadirian P, Tung N, Olivotto IA, Foulkes WD, Warner E, Olopade O, Eisen A, Weber B, McLennan J, Sun P, Narod SA. The risk of ovarian cancer after breast cancer in BRCA1 and BRCA2 carriers. Gynecologic Oncology. 96: 222-6. PMID 15589605 DOI: 10.1016/J.Ygyno.2004.09.039 |
0.723 |
|
| 2005 |
Esplen M, Hunter J, Leszcz M, Warner E, Narod S, Butler K, Glendon G, Liedem A, Metcalfe K, DiProspero L, Kieffer S, Young M, Irwin E, Wong J. Supportive-expressive group therapy for women with brca1/2mutations: Results of a phase II trial Nursing and Health Sciences. 7: 146-146. DOI: 10.1111/J.1442-2018.2005.00233_12.X |
0.581 |
|
| 2004 |
Esplen MJ, Hunter J, Leszcz M, Warner E, Narod S, Metcalfe K, Glendon G, Butler K, Liede A, Young MA, Kieffer S, DiProspero L, Irwin E, Wong J. A multicenter study of supportive-expressive group therapy for women with BRCA1/BRCA2 mutations. Cancer. 101: 2327-40. PMID 15478194 DOI: 10.1002/Cncr.20661 |
0.565 |
|
| 2004 |
Metcalfe KA. Prophylactic bilateral mastectomy for breast cancer prevention. Journal of Women's Health (2002). 13: 822-9. PMID 15385076 DOI: 10.1089/Jwh.2004.13.822 |
0.662 |
|
| 2004 |
Metcalfe KA, Semple JL, Narod SA. Satisfaction with breast reconstruction in women with bilateral prophylactic mastectomy: a descriptive study. Plastic and Reconstructive Surgery. 114: 360-6. PMID 15277800 DOI: 10.1097/01.Prs.0000131877.52740.0E |
0.694 |
|
| 2004 |
Metcalfe K, Lynch HT, Ghadirian P, Tung N, Olivotto I, Warner E, Olopade OI, Eisen A, Weber B, McLennan J, Sun P, Foulkes WD, Narod SA. Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 2328-35. PMID 15197194 DOI: 10.1200/Jco.2004.04.033 |
0.712 |
|
| 2004 |
Menkiszak J, Rzepka-Górska I, Górski B, Gronwald J, Byrski T, Huzarski T, Jakubowska A, Metcalfe KA, Narod SA, Lubiński J. Attitudes toward preventive oophorectomy among BRCA1 mutation carriers in Poland. European Journal of Gynaecological Oncology. 25: 93-5. PMID 15053071 |
0.647 |
|
| 2004 |
Foulkes WD, Metcalfe K, Sun P, Hanna WM, Lynch HT, Ghadirian P, Tung N, Olopade OI, Weber BL, McLennan J, Olivotto IA, Bégin LR, Narod SA. Estrogen receptor status in BRCA1- and BRCA2-related breast cancer: the influence of age, grade, and histological type. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 2029-34. PMID 15041722 DOI: 10.1158/1078-0432.Ccr-03-1061 |
0.662 |
|
| 2004 |
Metcalfe KA, Esplen MJ, Goel V, Narod SA. Psychosocial functioning in women who have undergone bilateral prophylactic mastectomy. Psycho-Oncology. 13: 14-25. PMID 14745742 DOI: 10.1002/Pon.726 |
0.629 |
|
| 2003 |
Foulkes WD, Metcalfe K, Hanna W, Lynch HT, Ghadirian P, Tung N, Olopade O, Weber B, McLennan J, Olivotto IA, Sun P, Chappuis PO, Bégin LR, Brunet JS, Narod SA. Disruption of the expected positive correlation between breast tumor size and lymph node status in BRCA1-related breast carcinoma. Cancer. 98: 1569-77. PMID 14534871 DOI: 10.1002/Cncr.11688 |
0.544 |
|
| 2003 |
Metcalfe KA, Liede A, Trinkaus M, Hanna D, Narod SA. Evaluation of the needs of spouses of female carriers of mutations in BRCA1 and BRCA2. Clinical Genetics. 62: 464-9. PMID 12485194 DOI: 10.1034/J.1399-0004.2002.620607.X |
0.619 |
|
| 2002 |
Metcalfe KA, Narod SA. Breast cancer risk perception among women who have undergone prophylactic bilateral mastectomy. Journal of the National Cancer Institute. 94: 1564-9. PMID 12381709 DOI: 10.1093/Jnci/94.20.1564 |
0.725 |
|
| 2002 |
Metcalfe KA, Goel V, Lickley L, Semple J, Narod SA. Prophylactic bilateral mastectomy: patterns of practice. Cancer. 95: 236-42. PMID 12124821 DOI: 10.1002/Cncr.10680 |
0.574 |
|
| 2000 |
Metcalfe KA, Liede A, Hoodfar E, Scott A, Foulkes WD, Narod SA. An evaluation of needs of female BRCA1 and BRCA2 carriers undergoing genetic counselling. Journal of Medical Genetics. 37: 866-74. PMID 11073541 DOI: 10.1136/Jmg.37.11.866 |
0.748 |
|
| 2000 |
Liede A, Metcalfe K, Hanna D, Hoodfar E, Snyder C, Durham C, Lynch HT, Narod SA. Evaluation of the needs of male carriers of mutations in BRCA1 or BRCA2 who have undergone genetic counseling. American Journal of Human Genetics. 67: 1494-504. PMID 11063672 DOI: 10.1086/316907 |
0.701 |
|
| Show low-probability matches. |